According to a recent report, in patients with stage III−IV breast cancer, Glo1 and PKCλ may be cooperatively involved in cancer progression and patients with high Glo1 and PKCλ expression had worse prognosis (87). This evidence concerns the gene GLO1 and breast cancer.